Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
The present work relates to a process to prepare Ceritinib formulation in the form of nanoparticles and the use of nanoparticle composition for the treatment of non-small-cell lung cancer. In this study Anticancer compositions comprising anticancer agents in the form of surface modified nanoparticles as obtained through the process according to the invention exhibit reduced toxicity and/or enhanced efficacy. It is a particularly advantageous feature of this invention that a process for obtaining anticancer compositions is provided, which compositions exhibit reduced toxicity and/or improved efficacy.